The association between uncarboxylated matrix Gla protein and lipoprotein-associated phospholipase A(2)
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F15%3A%230001081" target="_blank" >RIV/00064190:_____/15:#0001081 - isvavai.cz</a>
Alternative codes found
RIV/00159816:_____/15:00061248 RIV/00216208:11110/15:10282629 RIV/00216208:11140/15:10282629 RIV/00669806:_____/15:10282629
Result on the web
<a href="http://dx.doi.org/10.1016/j.maturitas.2014.10.003" target="_blank" >http://dx.doi.org/10.1016/j.maturitas.2014.10.003</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.maturitas.2014.10.003" target="_blank" >10.1016/j.maturitas.2014.10.003</a>
Alternative languages
Result language
angličtina
Original language name
The association between uncarboxylated matrix Gla protein and lipoprotein-associated phospholipase A(2)
Original language description
Background: Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is independently associated with cardiovascular risk, probably via inflammatory activity in sclerotic plaque. We speculated whether Lp-PLA(2) has a role in the aetiology of vascular calcifications, estimated from circulating uncarboxylated matrix Gla protein (MGP) species and whether we could find a potential interaction of Lp-PLA(2) and MGP in terms of mortality. Materials and Methods: We examined 798 patients (mean age 65.1 years) with stable vascular disease and followed them in a prospective study. Both, desphospho-uncarboxylated and total MGP (dp-ucMGP or t-ucMGP) were quantified by pre-commercial ELISA assays, developed by VitaK (Maastricht, The Netherland) Results: Lp-PLA(2) activity was independently positively associated with desphospho-uncarboxylated MGP (dp-ucMGP) [beta coeff = 0.098, p = 0.006]. 1SD of Lp-PLA(2) activity was associated with 37% increased risk (p = 0.001) of elevated dp-ucMGP (>= 977 pmol/L, top quartile). In the Cox proportional hazard model adjusted for conventional risk factors, the patients in the highest quartile of dp-ucMGP or lowest quintile of total-uncarboxylated ucMGP (<2660 nmol/L) had higher risk of all-cause mortality [HRR 2.79 (95% CI 1.97-3.94) and HRR 1.69 (95% CI 1.18-2.42), respectively]. We observed no effect of high Lp-PLA(2) activity (>= 195 nmol/min/mL) on total mortality. Conclusions: We assume that Lp-PLA(2) is involved in vascular calcification and that dp-ucMGP is a more appropriate biomarker of residual risk than Lp-PLA(2) itself.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
MATURITAS
ISSN
0378-5122
e-ISSN
—
Volume of the periodical
80
Issue of the periodical within the volume
1
Country of publishing house
IE - IRELAND
Number of pages
7
Pages from-to
82-88
UT code for WoS article
000348013900013
EID of the result in the Scopus database
—